The “Global Covid-19 Vaccine Market – Analysis By Product Type, Patient Type, End User, By Region, By Country (2021 Edition): Market Insights, Competition and Forecast (2020-2030)” report has been added to ResearchAndMarkets.com’s offering.
The global Covid-19 vaccine market will be valued at approximately USD 25 billion in the year 2024. The growing government support for vaccine development and the increasing involvement of global organizations in the development of adequate vaccination facilities in endemic regions is anticipated to positively influence the sales of Coronavirus vaccine in the upcoming years. Moreover, the strong demand for coronavirus vaccine, the ongoing initiatives by governments to procure the vaccine and the waves of infection is likely to drive the market growth during the forecast period.
Under the Patient Type segment, the Covid-19 vaccine market for senior citizens is anticipated to witness the largest market share owing to the focus of the governments to vaccinate the vulnerable population, manufacturing of vaccines being outsourced and also manufacturers collaborating with hospitals and doctors to better understand their demand and meet their requirements will be pushing growth in the market for Covid-19 vaccine during the coming years.
Hospitals, followed by Clinics, Vaccination centers and Academic and research institutes will attain substantial market share as healthcare authorities and governments are trying their best to vaccinate the population to further avoid spread of coronavirus disease.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Among the regions, North America, followed by Europe and Asia Pacific, will experience remarkable growth owing to new waves of the spread of the virus, the emergence of mutant viruses, the presence of various leading global manufacturers in the region with companies ramping up their production capacity and a growing number of coronavirus patients.
Source: Globenewswire
